Sara Modig

488 total citations
22 papers, 316 citations indexed

About

Sara Modig is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Family Practice. According to data from OpenAlex, Sara Modig has authored 22 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Family Practice. Recurrent topics in Sara Modig's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Patient Safety and Medication Errors (5 papers). Sara Modig is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Patient Safety and Medication Errors (5 papers). Sara Modig collaborates with scholars based in Sweden, Qatar and Belarus. Sara Modig's co-authors include Patrik Midlöv, Åsa Bondesson, Jimmie Kristensson, Ingalill Rahm Hallberg, Anna Ekwall, Margareta Troein, Carl Johan Östgren, Sigvard Mölstad, Christina Lannering and Lydia Holmdahl and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Health Services Research and European Journal of Clinical Pharmacology.

In The Last Decade

Sara Modig

20 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Modig Sweden 10 188 83 81 56 50 22 316
Stefanie Thevelin Belgium 9 259 1.4× 80 1.0× 137 1.7× 55 1.0× 58 1.2× 10 299
Tischa van der Cammen Netherlands 11 279 1.5× 89 1.1× 132 1.6× 58 1.0× 52 1.0× 14 394
Virginie Korb‐Savoldelli France 11 173 0.9× 145 1.7× 50 0.6× 56 1.0× 85 1.7× 24 409
Sylvie D. Price Australia 7 237 1.3× 85 1.0× 108 1.3× 38 0.7× 39 0.8× 8 320
Christopher Hand United Kingdom 5 216 1.1× 103 1.2× 93 1.1× 83 1.5× 49 1.0× 12 364
Clementine C. M. Stuijt Netherlands 9 300 1.6× 94 1.1× 84 1.0× 58 1.0× 53 1.1× 14 372
Marjo J. A. Janssen Netherlands 9 261 1.4× 98 1.2× 61 0.8× 53 0.9× 101 2.0× 13 325
Maarit Dimitrow Finland 8 301 1.6× 99 1.2× 148 1.8× 50 0.9× 37 0.7× 18 337
Muriel Burk United States 11 153 0.8× 65 0.8× 90 1.1× 76 1.4× 40 0.8× 25 337
M Geurts Netherlands 6 252 1.3× 98 1.2× 101 1.2× 60 1.1× 36 0.7× 10 295

Countries citing papers authored by Sara Modig

Since Specialization
Citations

This map shows the geographic impact of Sara Modig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Modig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Modig more than expected).

Fields of papers citing papers by Sara Modig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Modig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Modig. The network helps show where Sara Modig may publish in the future.

Co-authorship network of co-authors of Sara Modig

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Modig. A scholar is included among the top collaborators of Sara Modig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Modig. Sara Modig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modig, Sara, et al.. (2025). Women’s experience of gestational diabetes and healthcare in southern Sweden – a qualitative study. BMC Pregnancy and Childbirth. 25(1). 224–224.
2.
Londos, Elisabet, et al.. (2023). Development of the Swedish anticholinergic burden scale (Swe-ABS). BMC Geriatrics. 23(1). 518–518. 7 indexed citations
3.
Bolmsjö, Beata Borgström, et al.. (2023). Clinical impact of medication reviews for community-dwelling patients in primary healthcare. BMC Primary Care. 24(1). 259–259. 1 indexed citations
4.
Calling, Susanna, et al.. (2023). Follow-up and screening for type-2 diabetes mellitus in women with previous gestational diabetes in primary care. Scandinavian Journal of Primary Health Care. 41(1). 98–103. 2 indexed citations
5.
6.
Modig, Sara, et al.. (2022). Assessment of medication discrepancies with point prevalence measurement: how accurate are the medication lists for Swedish patients?. Drugs & Therapy Perspectives. 38(4). 185–193. 1 indexed citations
7.
Londos, Elisabet, et al.. (2021). Medications causing potential cognitive impairment are common in nursing home dementia units – A cross-sectional study. SHILAP Revista de lepidopterología. 3. 100054–100054. 5 indexed citations
8.
Midlöv, Patrik, et al.. (2020). A descriptive study of pain treatment and its follow-up in primary care of elderly patients after orthopaedic care. Journal of Pharmaceutical Health Care and Sciences. 6(1). 10–10. 1 indexed citations
9.
Bondesson, Åsa, et al.. (2019). Medication errors in primary health care records; a cross-sectional study in Southern Sweden. BMC Family Practice. 20(1). 110–110. 14 indexed citations
10.
Modig, Sara, et al.. (2019). Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs. Drugs - Real World Outcomes. 7(1). 53–62. 34 indexed citations
11.
Strandberg, Eva Lena, et al.. (2018). Drugs, distrust and dialogue –a focus group study with Swedish GPs on discharge summary use in primary care. BMC Family Practice. 19(1). 127–127. 13 indexed citations
12.
Bondesson, Åsa, et al.. (2018). Elderly at risk in care transitions When discharge summaries are poorly transferred and used –a descriptive study. BMC Health Services Research. 18(1). 770–770. 22 indexed citations
13.
Modig, Sara & Sölve Elmståhl. (2018). Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population. International Journal of Clinical Pharmacy. 40(4). 870–877. 16 indexed citations
14.
15.
Modig, Sara, Lydia Holmdahl, & Åsa Bondesson. (2015). Medication reviews in primary care in Sweden: importance of clinical pharmacists’ recommendations on drug-related problems. International Journal of Clinical Pharmacy. 38(1). 41–45. 25 indexed citations
16.
Modig, Sara, Patrik Midlöv, & Jimmie Kristensson. (2014). Depressive symptoms among frail elderly in ordinary living: who is affected and who is treated?. Aging & Mental Health. 18(8). 1022–1028. 3 indexed citations
17.
Modig, Sara, Jimmie Kristensson, Margareta Troein, Annika Brorsson, & Patrik Midlöv. (2012). Frail elderly patients’ experiences of information on medication. A qualitative study. BMC Geriatrics. 12(1). 46–46. 37 indexed citations
18.
Modig, Sara, Christina Lannering, Carl Johan Östgren, Sigvard Mölstad, & Patrik Midlöv. (2011). The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study. BMC Geriatrics. 11(1). 1–1. 48 indexed citations
19.
Kristensson, Jimmie, Sara Modig, Patrik Midlöv, Ingalill Rahm Hallberg, & Ulf Jakobsson. (2010). Healthcare utilisation and knowledge concerning prescribed drugs among older people. European Journal of Clinical Pharmacology. 66(10). 1047–1054. 5 indexed citations
20.
Modig, Sara, Jimmie Kristensson, Anna Ekwall, Ingalill Rahm Hallberg, & Patrik Midlöv. (2008). Frail elderly patients in primary care—their medication knowledge and beliefs about prescribed medicines. European Journal of Clinical Pharmacology. 65(2). 151–155. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Thevelin Breakdown of academic impact, for papers by Tischa van der Cammen Breakdown of academic impact, for papers by Virginie Korb‐Savoldelli Breakdown of academic impact, for papers by Sylvie D. Price Breakdown of academic impact, for papers by Christopher Hand Breakdown of academic impact, for papers by Clementine C. M. Stuijt Breakdown of academic impact, for papers by Marjo J. A. Janssen Breakdown of academic impact, for papers by Maarit Dimitrow Breakdown of academic impact, for papers by Muriel Burk Breakdown of academic impact, for papers by M Geurts
Rankless by CCL
2026